Loading…
PDS Biotechnology Corporation is projected to rise to $0.7829 by 2027, a +10% move from its current price of $0.7144. PDSB is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $0.6901 | $0.7143 | $0.7394 | -0.01% |
| Aug 6 | $0.6802 | $0.7142 | $0.7499 | -0.03% |
| Aug 7 | $0.6727 | $0.7141 | $0.758 | -0.04% |
| Aug 8 | $0.6664 | $0.714 | $0.765 | -0.06% |
| Aug 9 | $0.6609 | $0.7139 | $0.7711 | -0.07% |
| Aug 10 | $0.656 | $0.7138 | $0.7767 | -0.09% |
| Aug 11 | $0.6514 | $0.7137 | $0.7819 | -0.10% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.6514 | $0.7137 | $0.7819 | -0.10% |
| Week 2 | $0.6267 | $0.713 | $0.8112 | -0.20% |
| Week 3 | $0.6081 | $0.7123 | $0.8342 | -0.30% |
| Week 4 | $0.5929 | $0.7116 | $0.854 | -0.40% |
| Week 5 | $0.5796 | $0.7108 | $0.8717 | -0.50% |
| Week 6 | $0.5679 | $0.7101 | $0.888 | -0.60% |
| Week 7 | $0.5573 | $0.7094 | $0.9031 | -0.70% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, developing a pipeline of targeted cancer immunotherapies in the United States.
The company's lead product candidate is PDS0101, a Versamune HPV, which is in phase II clinical trial for the treatment of head and neck, cervical, anal, vaginal, vulvar, and penile cancers.
PDS Biotechnology Corporation was founded in 2005 and is based in Princeton, New Jersey.
PDS Biotechnology Corporation (PDSB) is trading at $0.7005, with a market cap of $39.17M and a rank of 4553.
The asset sits in the Healthcare category and is currently positioned with a neutral near-term price outlook. The 2026 forecast shows an average price of $0.7005 with ROI 0 and sentiment NEUTRAL.
Longer-term forecasts point to higher levels, with 2030 avg $1.17, 2040 avg $1.80, and 2050 avg $4.22, accompanied by ROIs of 66.8, 157, and 502.7 respectively and bullish sentiment.
A major floor 32.1% below — a decisive break under it would weaken the trend.
The nearest floor, 6.2% below — buyers have tended to step in here.
The nearest ceiling, 33.7% above — a clean break opens room to run.
A major ceiling 100.2% above — clearing it would confirm fresh momentum.
Key PDSB support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of PDSB market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.6878 | Buy | $0.6905 | Buy |
| MA 10 | $0.7014 | Buy | $0.7044 | Buy |
| MA 20 | $0.7385 | Sell | $0.7471 | Sell |
| MA 50 | $0.9052 | Sell | $0.8471 | Sell |
| MA 100 | $0.9221 | Sell | $0.8931 | Sell |
| MA 200 | $0.8852 | Sell | $0.9774 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 35.93 | Neutral |
| Stoch RSI (14) | 70.21 | Neutral |
| CCI (20) | -82.64 | Neutral |
| Williams %R (14) | -82.22 | Info |
| MACD (12,26,9) | 0.01 | Buy |
| ROC (12) | -8.04 | Sell |
| Bollinger %B (20,2) | 0.24 | Neutral |
| Stochastic %K (14) | 17.78 | Buy |
| TRIX (15) | -1.17 | Sell |
| Awesome (5,34) | -0.13 | Sell |
| Ultimate (7,14,28) | 36.09 | Neutral |
| Momentum (10) | -0.05 | Sell |
| Aroon Osc (25) | -84.00 | Sell |
| Hull MA (9) | 0.68 | Buy |
| ADX (14) | 27.69 | Sell |
| ATR (14) | 0.03 | Info |
The 30-day technical picture is NEUTRAL. The RSI14 is 30, and the SMA50 is $0.9704 while the SMA200 is $0.8937.
Support is at $0.701 and resistance at $1.12, with a potential test of the near-term level around the current price.
The 30-day range runs from $0.5424 to $0.9047, indicating recent volatility within a relatively tight band for this price level.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.537 | $0.7144 | $0.9111 | 0% | Neutral | |
| $0.6097 | $0.7829 | $1.07 | +10% | Neutral | |
| $0.6442 | $0.8582 | $1.23 | +20% | Bullish | |
| $0.7265 | $0.9979 | $1.48 | +40% | Bullish | |
| $0.8684 | $1.23 | $1.87 | +72% | Bullish | |
| $0.8719 | $1.26 | $1.98 | +77% | Bullish | |
| $0.8675 | $1.28 | $2.06 | +80% | Bullish | |
| $0.8856 | $1.34 | $2.20 | +88% | Bullish | |
| $0.7963 | $1.23 | $2.05 | +72% | Bullish | |
| $0.952 | $1.50 | $2.55 | +110% | Bullish | |
| $1.15 | $1.99 | $3.63 | +178% | Bullish | |
| $2.22 | $4.52 | $9.17 | +533% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.537 | $0.7144 | $0.8606 | +0.00% |
| September 2026 | $0.6103 | $0.727 | $0.8942 | +1.77% |
| October 2026 | $0.5868 | $0.7052 | $0.8791 | -3.01% |
| November 2026 | $0.5654 | $0.6843 | $0.8624 | -2.95% |
| December 2026 | $0.5876 | $0.716 | $0.9111 | +4.62% |
Click any year to see its month-by-month PDSB forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, PDSB is projected to trade between $0.537 and $0.9111, averaging $0.7144 — a potential gain of 0% from today's $0.7144. Price action looks broadly range-bound.
PDS Biotechnology Corporation's 2027 outlook centres on $0.7829, within a $0.6097 to $1.07 range. That is up +10% on the projected 2026 average. That marks a +10% change versus current levels. A consolidation phase looks the most probable path here.
By 2028, PDSB could reach as high as $1.23, with a base case around $0.8582 and support toward $0.6442 — roughly +20% from $0.7144. Momentum favours further upside here.
Expect PDSB to range from $0.7265 to $1.48 through 2029. The $0.9979 average target implies a +40% move from current prices. That is up +16% on the projected 2028 average. Buyers look set to stay in control over this stretch.
The PDSB price prediction for 2030 points to an average of $1.23 (low $0.8684, high $1.87) — a potential gain of +72% on today's $0.7144. Momentum favours further upside here.
In 2031, PDSB is projected to trade between $0.8719 and $1.98, averaging $1.26 — a potential gain of +77% from today's $0.7144. That is up +3% on the projected 2030 average. Buyers look set to stay in control over this stretch.
PDS Biotechnology Corporation's 2032 outlook centres on $1.28, within a $0.8675 to $2.06 range. That is up +2% on the projected 2031 average. That marks a +80% change versus current levels. Momentum favours further upside here.
By 2033, PDSB could reach as high as $2.20, with a base case around $1.34 and support toward $0.8856 — roughly +88% from $0.7144. Buyers look set to stay in control over this stretch.
Expect PDSB to range from $0.7963 to $2.05 through 2034. The $1.23 average target implies a +72% move from current prices. That is -8% versus the projected 2033 average. Momentum favours further upside here.
The PDSB price prediction for 2035 points to an average of $1.50 (low $0.952, high $2.55) — a potential gain of +110% on today's $0.7144. Buyers look set to stay in control over this stretch.
In 2040, PDSB is projected to trade between $1.15 and $3.63, averaging $1.99 — a potential gain of +178% from today's $0.7144. That is up +32% on the projected 2035 average. Momentum favours further upside here.
PDS Biotechnology Corporation's 2050 outlook centres on $4.52, within a $2.22 to $9.17 range. That is up +128% on the projected 2040 average. That marks a +533% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in PDSB today (≈ 1,399.776036 PDSB) could be worth
$6,330.71
+$5,330.71 (+533%) by 2050 · US Dollar
Based on the average projected PDSB price of $4.52 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in PDSBwould be worth at today's price.
$1,000 invested in PDSB on Jul 31, 2025 (≈ 934.579393 PDSB) would be worth
$667.66
-$332.34 (-33.2%) today · 0.67× · US Dollar
Based on a PDSB entry price of $1.07 vs. today's $0.7144.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.681 | $1,049.05 | +4.9% |
| 1 month ago | $0.874 | $817.39 | -18.3% |
| 3 months ago | $0.981 | $728.24 | -27.2% |
| 6 months ago | $0.826 | $864.89 | -13.5% |
| 1 year ago | $1.07 | $667.66 | -33.2% |
| All time (5.0y) ago | $11.64 | $61.37 | -93.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our PDSB forecast.
Our base-case forecast reaches $1.40 around 2035.
Implied market cap at $1.40: $78.29M
The multi-year forecast shows a bullish path from 2026 through 2050. The 2026 average price is $0.7005 with ROI 0 and sentiment NEUTRAL, rising to $0.7426 in 2027 (ROI 6) and $0.8185 in 2028 (ROI 16.8).
By 2029 the avg price is $0.9623 with ROI 37.4 and a BULLISH sentiment, and by 2030 the avg rises to $1.17 with ROI 66.8 and a BULLISH sentiment.
The forecast continues with 2031 avg $1.22 (ROI 73.9), 2032 avg $1.22 (ROI 74.7), and 2033 avg $1.23 (ROI 75.7), followed by 2034 avg $1.14 (ROI 62.2) and 2035 avg $1.41 (ROI 100.6) with bullish momentum.
In 2040 the avg price is $1.80 with ROI 157 and a BULLISH sentiment, and in 2050 the avg price is $4.22 with ROI 502.7 and a BULLISH sentiment.
Tap a question to reveal the answer.
2030 avg price $1.17 with ROI 66.8 and sentiment BULLISH.
Long-term forecasts show upside, with 2050 avg $4.22, max $9.02, ROI 502.7 and sentiment BULLISH; near term includes 2026 ROI 0 and 2027 ROI 6, indicating uncertainty.
Yes. The 2040 max is $3.44 and the 2050 max is $9.02.
The current price is $0.7005.
2050 avg $4.22; min $1.90; max $9.02; ROI 502.7; sentiment BULLISH.
PDS Biotechnology Corporation Community Discussion
0Share your PDS Biotechnology Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.